Pharma Pulse: CDC Leadership Controversy, Physician Mental Health Challenges, and Eli Lilly’s $5B US Manufacturing Expansion

This episode of Pharma Pulse covers the former CDC director’s claim she was dismissed for refusing to prioritize ideology over evidence, new findings that physician mental health remains a serious concern, and Eli Lilly’s $5 billion investment in a new Virginia manufacturing plant to expand biologics production.